Molecular basis of beta-lactamase induction in bacteria-Reference-Cited by-同舟云学术

Molecular basis of beta-lactamase induction in bacteria

Published:1993-02 Issue:2 Volume:37 Page:153-158
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Bennett P M¹,Chopra I¹

Affiliation:

1. Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, United Kingdom.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.37.2.153

Reference44 articles.

1. Abraham E. P. and S. G. Waley. 1979. P-Lactamases from Bacillus cereus p. 311-338. In J. M. T. Hamilton-Miller and J. T. Smith (ed.) Beta-lactamases. Academic Press Inc. London.

2. Inducible ,B-lactamases are principally responsible for the naturally occurring resistance towards 3-lactam antibiotics in Proteus vulgaris;Aspiotis A.;Chemotherapy,1986

3. Purification and mutant analysis of Citrobacter freundii AmpR, the regulator for chromosomal AmpC 3-lactamase;Bartowsky E.;Mol. Microbiol.,1991

4. Cell shape and division in Eschenchia coli: experiments with shape and division mutants;Begg K. J.;J. Bacteriol.,1985

5. Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria;Bergstrom S.;J. Bacteriol.,1982

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic changes associated with polysaccharide utilization reduce susceptibility to some β-lactams in Bacteroides thetaiotaomicron;mSphere;2024-08-28

2. Characterization of GQA as a novel β-lactamase inhibitor of CTX-M-15 and KPC-2 enzymes;Microbial Cell Factories;2024-08-08

3. Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome;Pathogens;2023-09-03

4. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

5. Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics;Infectious Disease Clinics of North America;2022-12